Patients with newly diagnosed gastric or gastroesophageal junction (GEJ) cancer who received the PD-L1 inhibitor durvalumab ...

Today, cancer stage and tumor size tell which patients will receive adjuvant chemotherapy. But the rise of biomarker testing ...

A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from ...

Exposure to wildfire smoke may increase lung cancer patients' risk of dying from their disease, particularly among ...

CHICAGO -- Biomarker-driven adjuvant therapy for intermediate/high-risk non-small cell lung cancer (NSCLC) led to ...

There are two main types of lung cancer: non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Several subtypes exist within these categories, and there are a few other ...

Accurate staging of the mediastinal lymph nodes in resectable non–small-cell lung cancer (NSCLC) is critically important to determine the overall stage of the tumor and guide subsequent management.

the American Joint Committee on Cancer (AJCC) updated the staging system that has been in effect since 2010. The new system officially launched in 2018. (3) Melanoma staging is extremely complex ...

1Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. 3Shanghai Clinical ...

There are notable changes in the updated American Joint Committee on Cancer (AJCC) staging manual for oropharyngeal cancer (OPC). 1 The epidemiology of OPC has necessitated drastic changes in the ...

“I’m a glass half full. I am positive and optimistic and if we’re fighting, I’m going to be the healthiest lung cancer patient they’ve ever had,” Duhamel encouragingly said.

A California man battling lung cancer is unable to get treatment he planned for after being denied by his health insurance company Cigna Healthcare. Daron Wells, a 59-year-old man with stage 4 ...